๏ปฟ
  ์•Œ๋ณด์   ์ฝ”๋ฆฌ์•„ โ€œ20๋Œ€ ๋น„ํ˜ผ์—ฌ์„ฑ 10๋ช… ์ค‘ 9๋ช…, ์›์น˜ ์•Š๋Š” ์ž„์‹ ์— ๋Œ€ํ•œ ๋ถˆ์•ˆ๊ฐ ๋Š๊ปด๋ณธ ์  ์žˆ์–ดโ€
  ์ง„๋งคํŠธ๋ฆญ์Šค, ์ž๊ถ๊ฒฝ๋ถ€์•” ์ง„๋‹จ์ œ ์‚ผ๊ด‘์˜๋ฃŒ์žฌ๋‹จ์— ๊ณต๊ธ‰ ํ™•์ •
  ๋‰ด๋Ÿด์Šคํ…œ NSI-189, FDA๋กœ๋ถ€ํ„ฐ ์—”์ ค๋งŒ์ฆํ›„๊ตฐ ์น˜๋ฃŒ์šฉ ํฌ๊ท€์˜์•ฝํ’ˆ์œผ๋กœ ์ง€์ •
  Merz Creates Americas Region, Expands Bob Rhatiganโ€™s Leadership Role
  ๋‰ด๋Ÿด์Šคํ…œ, ์ง ์Šค์ปฌ๋ฆฌ๋ฅผ ์ตœ๊ณ ๊ฒฝ์˜์ž ์ง๋ฌด๋Œ€ํ–‰์œผ๋กœ ์ž„๋ช…
  Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
  Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa
  ์„ธํฌ์น˜๋ฃŒ ์›”๋“œ ์•„์‹œ์•„ ์ปจํผ๋Ÿฐ์Šค 9์›” ๊ฐœ์ตœ